CNBC Earnings

Polestar is still on track to build 60,000 to 70,000 EVs in 2023, with two new models coming in the next several months.

Lululemon raised its full year guidance and saw its sales and profit rise 18% during its most recent quarter, fueled by a 61% boost in China.

Swedish buy now, pay later firm Klarna reduced losses by roughly 67% in the first half of 2023, as it cut costs dramatically in a bid for profitability.

UBS posted second-quarter profit of $28.9 billion in its first quarterly earnings since Switzerland's largest bank completed its takeover of Credit Suisse.

Salesforce saw gains in all five product categories, and CEO Marc Benioff sees more growth from artificial intelligence capabilities

Shares of HP fell Wednesday after the company missed analysts' expectations for revenue.

The company saw some growth across its ready-to-drink and tequila categories, but whiskey sales lagged.

While other toy companies have been hammered by a slump in toy demand this year, Lego is one of the few to post positive gains.

Nio's second-quarter loss widened from a year ago, as it overhauled key products amid an economic slowdown in China. But deliveries are already rebounding.

While Best Buy trimmed its sales guidance for the year, it raised the bottom end of its profit outlook.

Chinese automaker BYD on Monday posted a 204.68% jump in profit in the first half of the year driven by record deliveries.

Meituan shares fell 5% Friday after CEO Wang Xing warned of a food delivery slowdown in the third quarter during the firm's latest earnings call on Thursday.

Gap reported mixed results on Thursday and underwhelming current-quarter guidance.

The department store retailer stuck by its forecast for the full year, despite better-than-expected results.

Dollar Tree raised its sales outlook for the year but narrowed its earnings guidance.

Australia's Qantas announced a record annual profit on Thursday, and announced a share buyback and a multi-billion dollar order for 24 new aircrafts.

Revenue in the second quarter doubled from $6.7 billion a year earlier and increased 88% from the prior period.

CVS is looking to strengthen its foothold in the biosimilars market, which is expected to grow to $100 billion over the next six years.

Peloton's shares plunged 22% after the company posted a wider-than-expected loss and churn that it blamed on its Bike seat recall and seasonality.

Athletic apparel retailer Foot Locker reported another quarterly sales decline and missed revenue expectations as consumers continue to pull back from shoes.